Novel cancer winner

16 February 2009

PhD student Emily Davis has won the international Roche Young Researcher Award for her research into novel treatments for cancer.

Davis, a postgraduate student in the Department of Human Biology, investigates how Tbx2, a protein that plays an important role during the embryonic development of many species, causes cells to become cancerous.

Her work reveals one of the mechanisms by which the Tbx2 protein contributes to oncogenesis and was published in leading cancer journal Oncogene.

The importance of Davis' work was underscored by her supervisor, Dr Sharon Prince, who said it would play an important role in the development of new cancer drugs.

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Please view the republishing articles page for more information.

Latest articles

TLC 2024: Automation can change students’ lives On day one of the 2024 Teaching and Learning Conference, Professor Hussein Suleman discussed automation for transformation in learning spaces. 22 Nov 2024

Falling short of objectives: the ANC, the people and the GNU After 30 years of democracy and a new government, there are lessons we can learn from the ANC not achieving its objectives, says Dr Moferefere Lekorotsoana. 22 Nov 2024

SASMA presidency: Dr Sharief Hendricks leaves on a high After two years as president of the South African Sports Medicine Association, Dr Sharief Hendricks reflects on deliberate growth. 22 Nov 2024

UCT brewing team triumphs at national intervarsity competition Brewing UCT clinched multiple awards at the South African Intervarsity Brewing Challenge in Bloemfontein. 21 Nov 2024

UCT physios pay it forward to Hanover Park community UCT physiotherapists volunteered their time and expertise in a Health for Humanity initiative in Hanover Park. 20 Nov 2024